Get Real Time Here
| Open5.150 | Close- |
| Vol / Avg.17.985K / 161.626K | Mkt Cap111.213M |
| Day Range4.940 - 5.277 | 52 Wk Range1.560 - 9.250 |
Reviva Pharmaceuticals Stock (NASDAQ:RVPH), Quotes and News Summary
Reviva Pharmaceuticals Stock (NASDAQ: RVPH) stock price, news, charts, stock research, profile.
| Open5.150 | Close- |
| Vol / Avg.17.985K / 161.626K | Mkt Cap111.213M |
| Day Range4.940 - 5.277 | 52 Wk Range1.560 - 9.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.280 | -0.550 | -0.2700 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-20 | Roth MKM | Scott Henry | Initiates Coverage On | Buy | Announces | - | 12.00 |
| 2023-08-16 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-26 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-08 | Benchmark | Bruce Jackson | Initiates Coverage On | Speculative Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| RVPH | Reviva Pharmaceuticals | -2.77% | 111.2M |
| ZVRA | Zevra Therapeutics | -2.72% | 174.5M |
| SCYX | SCYNEXIS | -1.09% | 84.6M |
| LBPH | Longboard Pharmaceuticals | 7.83% | 136M |
| AQST | Aquestive Therapeutics | 2% | 102.1M |
How do I buy Reviva Pharmaceuticals (RVPH) stock?
You can purchase shares of Reviva Pharmaceuticals (NASDAQ: RVPH) through any online brokerage.
Who are Reviva Pharmaceuticals's (RVPH) competitors?
Other companies in Reviva Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Reviva Pharmaceuticals (RVPH) stock?
The latest price target for Reviva Pharmaceuticals (NASDAQ: RVPH) was reported by Roth MKM on Wednesday, September 20, 2023. The analyst firm set a price target for 12.00 expecting RVPH to rise to within 12 months (a possible 144.40% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Reviva Pharmaceuticals (RVPH)?
The stock price for Reviva Pharmaceuticals (NASDAQ: RVPH) is $4.91 last updated Today at September 29, 2023 at 3:53 PM UTC.
Does Reviva Pharmaceuticals (RVPH) pay a dividend?
There is no dividend information for Reviva Pharmaceuticals.
When is Reviva Pharmaceuticals (NASDAQ:RVPH) reporting earnings?
Reviva Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Reviva Pharmaceuticals (RVPH) going to split?
There is no upcoming split for Reviva Pharmaceuticals.
What sector and industry does Reviva Pharmaceuticals (RVPH) operate in?
Reviva Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Reviva Pharmaceuticals Stock (NASDAQ:RVPH), Quotes and News Summary
Reviva Pharmaceuticals Stock (NASDAQ: RVPH) stock price, news, charts, stock research, profile.
| Open5.150 | Close- |
| Vol / Avg.17.985K / 161.626K | Mkt Cap111.213M |
| Day Range4.940 - 5.277 | 52 Wk Range1.560 - 9.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.280 | -0.550 | -0.2700 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-20 | Roth MKM | Scott Henry | Initiates Coverage On | Buy | Announces | - | 12.00 |
| 2023-08-16 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-26 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-08 | Benchmark | Bruce Jackson | Initiates Coverage On | Speculative Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| RVPH | Reviva Pharmaceuticals | -2.77% | 111.2M |
| ZVRA | Zevra Therapeutics | -2.72% | 174.5M |
| SCYX | SCYNEXIS | -1.09% | 84.6M |
| LBPH | Longboard Pharmaceuticals | 7.83% | 136M |
| AQST | Aquestive Therapeutics | 2% | 102.1M |
How do I buy Reviva Pharmaceuticals (RVPH) stock?
You can purchase shares of Reviva Pharmaceuticals (NASDAQ: RVPH) through any online brokerage.
Who are Reviva Pharmaceuticals's (RVPH) competitors?
Other companies in Reviva Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Reviva Pharmaceuticals (RVPH) stock?
The latest price target for Reviva Pharmaceuticals (NASDAQ: RVPH) was reported by Roth MKM on Wednesday, September 20, 2023. The analyst firm set a price target for 12.00 expecting RVPH to rise to within 12 months (a possible 144.40% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Reviva Pharmaceuticals (RVPH)?
The stock price for Reviva Pharmaceuticals (NASDAQ: RVPH) is $4.91 last updated Today at September 29, 2023 at 3:53 PM UTC.
Does Reviva Pharmaceuticals (RVPH) pay a dividend?
There is no dividend information for Reviva Pharmaceuticals.
When is Reviva Pharmaceuticals (NASDAQ:RVPH) reporting earnings?
Reviva Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Reviva Pharmaceuticals (RVPH) going to split?
There is no upcoming split for Reviva Pharmaceuticals.
What sector and industry does Reviva Pharmaceuticals (RVPH) operate in?
Reviva Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Reviva Pharmaceuticals Stock (NASDAQ:RVPH), Quotes and News Summary
Reviva Pharmaceuticals Stock (NASDAQ: RVPH) stock price, news, charts, stock research, profile.
| Open5.150 | Close- |
| Vol / Avg.17.985K / 161.626K | Mkt Cap111.213M |
| Day Range4.940 - 5.277 | 52 Wk Range1.560 - 9.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.280 | -0.550 | -0.2700 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-20 | Roth MKM | Scott Henry | Initiates Coverage On | Buy | Announces | - | 12.00 |
| 2023-08-16 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-26 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-08 | Benchmark | Bruce Jackson | Initiates Coverage On | Speculative Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| RVPH | Reviva Pharmaceuticals | -2.77% | 111.2M |
| ZVRA | Zevra Therapeutics | -2.72% | 174.5M |
| SCYX | SCYNEXIS | -1.09% | 84.6M |
| LBPH | Longboard Pharmaceuticals | 7.83% | 136M |
| AQST | Aquestive Therapeutics | 2% | 102.1M |
How do I buy Reviva Pharmaceuticals (RVPH) stock?
You can purchase shares of Reviva Pharmaceuticals (NASDAQ: RVPH) through any online brokerage.
Who are Reviva Pharmaceuticals's (RVPH) competitors?
Other companies in Reviva Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Reviva Pharmaceuticals (RVPH) stock?
The latest price target for Reviva Pharmaceuticals (NASDAQ: RVPH) was reported by Roth MKM on Wednesday, September 20, 2023. The analyst firm set a price target for 12.00 expecting RVPH to rise to within 12 months (a possible 144.40% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Reviva Pharmaceuticals (RVPH)?
The stock price for Reviva Pharmaceuticals (NASDAQ: RVPH) is $4.91 last updated Today at September 29, 2023 at 3:53 PM UTC.
Does Reviva Pharmaceuticals (RVPH) pay a dividend?
There is no dividend information for Reviva Pharmaceuticals.
When is Reviva Pharmaceuticals (NASDAQ:RVPH) reporting earnings?
Reviva Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Reviva Pharmaceuticals (RVPH) going to split?
There is no upcoming split for Reviva Pharmaceuticals.
What sector and industry does Reviva Pharmaceuticals (RVPH) operate in?
Reviva Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Reviva Pharmaceuticals Stock (NASDAQ:RVPH), Quotes and News Summary
Reviva Pharmaceuticals Stock (NASDAQ: RVPH) stock price, news, charts, stock research, profile.
| Open5.150 | Close- |
| Vol / Avg.17.985K / 161.626K | Mkt Cap111.213M |
| Day Range4.940 - 5.277 | 52 Wk Range1.560 - 9.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.280 | -0.550 | -0.2700 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-20 | Roth MKM | Scott Henry | Initiates Coverage On | Buy | Announces | - | 12.00 |
| 2023-08-16 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-26 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-08 | Benchmark | Bruce Jackson | Initiates Coverage On | Speculative Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| RVPH | Reviva Pharmaceuticals | -2.77% | 111.2M |
| ZVRA | Zevra Therapeutics | -2.72% | 174.5M |
| SCYX | SCYNEXIS | -1.09% | 84.6M |
| LBPH | Longboard Pharmaceuticals | 7.83% | 136M |
| AQST | Aquestive Therapeutics | 2% | 102.1M |
How do I buy Reviva Pharmaceuticals (RVPH) stock?
You can purchase shares of Reviva Pharmaceuticals (NASDAQ: RVPH) through any online brokerage.
Who are Reviva Pharmaceuticals's (RVPH) competitors?
Other companies in Reviva Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Reviva Pharmaceuticals (RVPH) stock?
The latest price target for Reviva Pharmaceuticals (NASDAQ: RVPH) was reported by Roth MKM on Wednesday, September 20, 2023. The analyst firm set a price target for 12.00 expecting RVPH to rise to within 12 months (a possible 144.40% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Reviva Pharmaceuticals (RVPH)?
The stock price for Reviva Pharmaceuticals (NASDAQ: RVPH) is $4.91 last updated Today at September 29, 2023 at 3:53 PM UTC.
Does Reviva Pharmaceuticals (RVPH) pay a dividend?
There is no dividend information for Reviva Pharmaceuticals.
When is Reviva Pharmaceuticals (NASDAQ:RVPH) reporting earnings?
Reviva Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Reviva Pharmaceuticals (RVPH) going to split?
There is no upcoming split for Reviva Pharmaceuticals.
What sector and industry does Reviva Pharmaceuticals (RVPH) operate in?
Reviva Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Reviva Pharmaceuticals Stock (NASDAQ:RVPH), Quotes and News Summary
Reviva Pharmaceuticals Stock (NASDAQ: RVPH) stock price, news, charts, stock research, profile.
| Open5.150 | Close- |
| Vol / Avg.17.985K / 161.626K | Mkt Cap111.213M |
| Day Range4.940 - 5.277 | 52 Wk Range1.560 - 9.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.280 | -0.550 | -0.2700 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-20 | Roth MKM | Scott Henry | Initiates Coverage On | Buy | Announces | - | 12.00 |
| 2023-08-16 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-26 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-08 | Benchmark | Bruce Jackson | Initiates Coverage On | Speculative Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| RVPH | Reviva Pharmaceuticals | -2.77% | 111.2M |
| ZVRA | Zevra Therapeutics | -2.72% | 174.5M |
| SCYX | SCYNEXIS | -1.09% | 84.6M |
| LBPH | Longboard Pharmaceuticals | 7.83% | 136M |
| AQST | Aquestive Therapeutics | 2% | 102.1M |
How do I buy Reviva Pharmaceuticals (RVPH) stock?
You can purchase shares of Reviva Pharmaceuticals (NASDAQ: RVPH) through any online brokerage.
Who are Reviva Pharmaceuticals's (RVPH) competitors?
Other companies in Reviva Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Reviva Pharmaceuticals (RVPH) stock?
The latest price target for Reviva Pharmaceuticals (NASDAQ: RVPH) was reported by Roth MKM on Wednesday, September 20, 2023. The analyst firm set a price target for 12.00 expecting RVPH to rise to within 12 months (a possible 144.40% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Reviva Pharmaceuticals (RVPH)?
The stock price for Reviva Pharmaceuticals (NASDAQ: RVPH) is $4.91 last updated Today at September 29, 2023 at 3:53 PM UTC.
Does Reviva Pharmaceuticals (RVPH) pay a dividend?
There is no dividend information for Reviva Pharmaceuticals.
When is Reviva Pharmaceuticals (NASDAQ:RVPH) reporting earnings?
Reviva Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Reviva Pharmaceuticals (RVPH) going to split?
There is no upcoming split for Reviva Pharmaceuticals.
What sector and industry does Reviva Pharmaceuticals (RVPH) operate in?
Reviva Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Reviva Pharmaceuticals Stock (NASDAQ:RVPH), Quotes and News Summary
Reviva Pharmaceuticals Stock (NASDAQ: RVPH) stock price, news, charts, stock research, profile.
| Open5.150 | Close- |
| Vol / Avg.17.985K / 161.626K | Mkt Cap111.213M |
| Day Range4.940 - 5.277 | 52 Wk Range1.560 - 9.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.280 | -0.550 | -0.2700 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-20 | Roth MKM | Scott Henry | Initiates Coverage On | Buy | Announces | - | 12.00 |
| 2023-08-16 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-26 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-08 | Benchmark | Bruce Jackson | Initiates Coverage On | Speculative Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| RVPH | Reviva Pharmaceuticals | -2.77% | 111.2M |
| ZVRA | Zevra Therapeutics | -2.72% | 174.5M |
| SCYX | SCYNEXIS | -1.09% | 84.6M |
| LBPH | Longboard Pharmaceuticals | 7.83% | 136M |
| AQST | Aquestive Therapeutics | 2% | 102.1M |
How do I buy Reviva Pharmaceuticals (RVPH) stock?
You can purchase shares of Reviva Pharmaceuticals (NASDAQ: RVPH) through any online brokerage.
Who are Reviva Pharmaceuticals's (RVPH) competitors?
Other companies in Reviva Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Reviva Pharmaceuticals (RVPH) stock?
The latest price target for Reviva Pharmaceuticals (NASDAQ: RVPH) was reported by Roth MKM on Wednesday, September 20, 2023. The analyst firm set a price target for 12.00 expecting RVPH to rise to within 12 months (a possible 144.40% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Reviva Pharmaceuticals (RVPH)?
The stock price for Reviva Pharmaceuticals (NASDAQ: RVPH) is $4.91 last updated Today at September 29, 2023 at 3:53 PM UTC.
Does Reviva Pharmaceuticals (RVPH) pay a dividend?
There is no dividend information for Reviva Pharmaceuticals.
When is Reviva Pharmaceuticals (NASDAQ:RVPH) reporting earnings?
Reviva Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Reviva Pharmaceuticals (RVPH) going to split?
There is no upcoming split for Reviva Pharmaceuticals.
What sector and industry does Reviva Pharmaceuticals (RVPH) operate in?
Reviva Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Reviva Pharmaceuticals Stock (NASDAQ:RVPH), Quotes and News Summary
Reviva Pharmaceuticals Stock (NASDAQ: RVPH) stock price, news, charts, stock research, profile.
| Open5.150 | Close- |
| Vol / Avg.17.985K / 161.626K | Mkt Cap111.213M |
| Day Range4.940 - 5.277 | 52 Wk Range1.560 - 9.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.280 | -0.550 | -0.2700 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-20 | Roth MKM | Scott Henry | Initiates Coverage On | Buy | Announces | - | 12.00 |
| 2023-08-16 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-26 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-08 | Benchmark | Bruce Jackson | Initiates Coverage On | Speculative Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| RVPH | Reviva Pharmaceuticals | -2.77% | 111.2M |
| ZVRA | Zevra Therapeutics | -2.72% | 174.5M |
| SCYX | SCYNEXIS | -1.09% | 84.6M |
| LBPH | Longboard Pharmaceuticals | 7.83% | 136M |
| AQST | Aquestive Therapeutics | 2% | 102.1M |
How do I buy Reviva Pharmaceuticals (RVPH) stock?
You can purchase shares of Reviva Pharmaceuticals (NASDAQ: RVPH) through any online brokerage.
Who are Reviva Pharmaceuticals's (RVPH) competitors?
Other companies in Reviva Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Reviva Pharmaceuticals (RVPH) stock?
The latest price target for Reviva Pharmaceuticals (NASDAQ: RVPH) was reported by Roth MKM on Wednesday, September 20, 2023. The analyst firm set a price target for 12.00 expecting RVPH to rise to within 12 months (a possible 144.40% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Reviva Pharmaceuticals (RVPH)?
The stock price for Reviva Pharmaceuticals (NASDAQ: RVPH) is $4.91 last updated Today at September 29, 2023 at 3:53 PM UTC.
Does Reviva Pharmaceuticals (RVPH) pay a dividend?
There is no dividend information for Reviva Pharmaceuticals.
When is Reviva Pharmaceuticals (NASDAQ:RVPH) reporting earnings?
Reviva Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Reviva Pharmaceuticals (RVPH) going to split?
There is no upcoming split for Reviva Pharmaceuticals.
What sector and industry does Reviva Pharmaceuticals (RVPH) operate in?
Reviva Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Reviva Pharmaceuticals Stock (NASDAQ:RVPH), Quotes and News Summary
Reviva Pharmaceuticals Stock (NASDAQ: RVPH) stock price, news, charts, stock research, profile.
| Open5.150 | Close- |
| Vol / Avg.17.985K / 161.626K | Mkt Cap111.213M |
| Day Range4.940 - 5.277 | 52 Wk Range1.560 - 9.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.280 | -0.550 | -0.2700 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-20 | Roth MKM | Scott Henry | Initiates Coverage On | Buy | Announces | - | 12.00 |
| 2023-08-16 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-26 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-08 | Benchmark | Bruce Jackson | Initiates Coverage On | Speculative Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| RVPH | Reviva Pharmaceuticals | -2.77% | 111.2M |
| ZVRA | Zevra Therapeutics | -2.72% | 174.5M |
| SCYX | SCYNEXIS | -1.09% | 84.6M |
| LBPH | Longboard Pharmaceuticals | 7.83% | 136M |
| AQST | Aquestive Therapeutics | 2% | 102.1M |
How do I buy Reviva Pharmaceuticals (RVPH) stock?
You can purchase shares of Reviva Pharmaceuticals (NASDAQ: RVPH) through any online brokerage.
Who are Reviva Pharmaceuticals's (RVPH) competitors?
Other companies in Reviva Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Reviva Pharmaceuticals (RVPH) stock?
The latest price target for Reviva Pharmaceuticals (NASDAQ: RVPH) was reported by Roth MKM on Wednesday, September 20, 2023. The analyst firm set a price target for 12.00 expecting RVPH to rise to within 12 months (a possible 144.40% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Reviva Pharmaceuticals (RVPH)?
The stock price for Reviva Pharmaceuticals (NASDAQ: RVPH) is $4.91 last updated Today at September 29, 2023 at 3:53 PM UTC.
Does Reviva Pharmaceuticals (RVPH) pay a dividend?
There is no dividend information for Reviva Pharmaceuticals.
When is Reviva Pharmaceuticals (NASDAQ:RVPH) reporting earnings?
Reviva Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Reviva Pharmaceuticals (RVPH) going to split?
There is no upcoming split for Reviva Pharmaceuticals.
What sector and industry does Reviva Pharmaceuticals (RVPH) operate in?
Reviva Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Reviva Pharmaceuticals Stock (NASDAQ:RVPH), Quotes and News Summary
Reviva Pharmaceuticals Stock (NASDAQ: RVPH) stock price, news, charts, stock research, profile.
| Open5.150 | Close- |
| Vol / Avg.17.985K / 161.626K | Mkt Cap111.213M |
| Day Range4.940 - 5.277 | 52 Wk Range1.560 - 9.250 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.280 | -0.550 | -0.2700 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-20 | Roth MKM | Scott Henry | Initiates Coverage On | Buy | Announces | - | 12.00 |
| 2023-08-16 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-26 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 10.00 |
| 2023-06-08 | Benchmark | Bruce Jackson | Initiates Coverage On | Speculative Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| RVPH | Reviva Pharmaceuticals | -2.77% | 111.2M |
| ZVRA | Zevra Therapeutics | -2.72% | 174.5M |
| SCYX | SCYNEXIS | -1.09% | 84.6M |
| LBPH | Longboard Pharmaceuticals | 7.83% | 136M |
| AQST | Aquestive Therapeutics | 2% | 102.1M |
How do I buy Reviva Pharmaceuticals (RVPH) stock?
You can purchase shares of Reviva Pharmaceuticals (NASDAQ: RVPH) through any online brokerage.
Who are Reviva Pharmaceuticals's (RVPH) competitors?
Other companies in Reviva Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), SCYNEXIS (NASDAQ:SCYX), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
What is the target price for Reviva Pharmaceuticals (RVPH) stock?
The latest price target for Reviva Pharmaceuticals (NASDAQ: RVPH) was reported by Roth MKM on Wednesday, September 20, 2023. The analyst firm set a price target for 12.00 expecting RVPH to rise to within 12 months (a possible 144.40% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Reviva Pharmaceuticals (RVPH)?
The stock price for Reviva Pharmaceuticals (NASDAQ: RVPH) is $4.91 last updated Today at September 29, 2023 at 3:53 PM UTC.
Does Reviva Pharmaceuticals (RVPH) pay a dividend?
There is no dividend information for Reviva Pharmaceuticals.
When is Reviva Pharmaceuticals (NASDAQ:RVPH) reporting earnings?
Reviva Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Reviva Pharmaceuticals (RVPH) going to split?
There is no upcoming split for Reviva Pharmaceuticals.
What sector and industry does Reviva Pharmaceuticals (RVPH) operate in?
Reviva Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.